Anti-TNF α PEG-Fab' antibody(Beijing Tri-Prime Genetic Engineering)

N/A

Report date: 2024/04/11 14:02:20

Base Information

Drug NameAnti-TNF α PEG-Fab' antibody(Beijing Tri-Prime Genetic Engineering)
Drug Alias Name抗TNF α PEG-Fab ’ 抗体
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Tri-Prime Gene Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tri-Prime Gene Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A